ASP : Acerus Pharmaceuticals Corporation Stock Profile

Last Updated: 3/12/2024 0:47:16

Acerus Pharmaceuticals Corporation trades with the ticker ASP on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina, a clinical stage product for women with female sexual dysfunction; and Noctiva combination products, which are in the pre-clinical development stage for the treatment of benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. It sells its products through its salesforce in the United States and Canada; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.

Looking to invest in Acerus Pharmaceuticals Corporation? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.

ASP.TO Stock Price and Key Stats

ETF Key Stats

Exchange: TSX

Market Cap : $2.775MM

PE Ratio:

Price: 0.01 (Updated: 3/12/2024 0:47:16)

Acerus Pharmaceuticals Corporation (ASP) vs Competitors in Drug Manufacturers – Specialty & Generic

Lets see how ASP.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:

Aleafia Health Inc, Aphria Inc, Correvio Pharma Corp, The Supreme Cannabis Company, Inc, Nuvo Pharmaceuticals Inc


Drug Manufacturers – Specialty & Generic Industry Comparisons

Company Market Cap ($MM) P/E Ratio EV/EBITDA Dividend Yield
Aleafia Health Inc (ALEF) $189.563 N/A 0.0 0.0%
Aphria Inc (APHA) $4,439.753 N/A 598.009 0.0%
Acerus Pharmaceuticals Corporation (ASP) $2.775 N/A -2.796 0.0%
Correvio Pharma Corp (CORV) $37.067 N/A 0.0 0.0%
The Supreme Cannabis Company, Inc (FIRE) $255.583 N/A 0.0 0.0%

EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield  

Comparisons within Drug Manufacturers – Specialty & Generic

  • Acerus Pharmaceuticals Corporation (ASP) vs Aleafia Health Inc (ALEF)
    • ALEF has higher EPS (-0.274 vs -4.41). ALEF has higher dividend yield (0.0% vs 0.0%). ALEF and ASP both have P/E’s under 0.
  • Acerus Pharmaceuticals Corporation (ASP) vs Aphria Inc (APHA)
    • APHA has higher EPS (0.116 vs -4.41). APHA has higher dividend yield (0.0% vs 0.0%). APHA and ASP both have P/E’s under 0.
  • Acerus Pharmaceuticals Corporation (ASP) vs Correvio Pharma Corp (CORV)
    • CORV has higher EPS (-0.879 vs -4.41). CORV has higher dividend yield (0.0% vs 0.0%). CORV and ASP both have P/E’s under 0.
  • Acerus Pharmaceuticals Corporation (ASP) vs The Supreme Cannabis Company, Inc (FIRE)
    • FIRE has higher EPS (-0.052 vs -4.41). FIRE has higher dividend yield (0.0% vs 0.0%). FIRE and ASP both have P/E’s under 0.
  • Acerus Pharmaceuticals Corporation (ASP) vs Nuvo Pharmaceuticals Inc (NRI)
    • NRI has higher EPS (0.024 vs -4.41). NRI has higher dividend yield (0.0% vs 0.0%). ASP has a P/E under 0, indicating NRI (P/E 2.6) is in a better position.

Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-2.80) than the industry average (2.71), indicating attractive valuation.

How to Buy ASP stock on the TSX

You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:

ImageProduct TitleFeaturesPrice
Editor's Choice
Wealthsimple Trade

Wealthsimple Trade

  • ETF buys and sells have $0 trading fees
  • Desktop and mobile trading
  • Reputable Brand
  • Beautiful Design
Get $25 Signup Bonus
Reliable Pick


  • ETF buys have $0 trading fees
  • Desktop and mobile trading
  • Most types of accounts available
Get $50 Free Stock Trades
Photo of author
Author Bio - Qayyum Rajan is a CFA Charterholder with 10+ years of finance experience and the co-creator of He has previously worked as a portfolio manager at RBC Dominion Securities and other roles at asset managers like Sentry Investments. He then started building websites and fintech apps to bring finance to everyone.

Check Out These Posts:

Leave a Comment